Sponsors (3)
Want to know what is actually in this bill?
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Amends section 1861(s)(2) by modifying subparagraph (JJ) (inserting text at its end) and by adding a new subparagraph (KK) to include treatments for dialysis-related amyloidosis.
Amends 42 U.S.C. 1395rr(b)(14)(B) by inserting additional text before the final period of that subsection's paragraph.
Amends 42 U.S.C. 1395l(a)(1)(E) by inserting additional text at the end of that provision.
This bill would require Medicare to cover and pay for treatments for dialysis-related amyloidosis. It defines these treatments as FDA‑approved items or services given in dialysis facilities, plus any supplies or services needed to deliver the treatment. It also says these treatments are separate from the usual “renal dialysis services” bundle, so they can be paid for on their own. The changes take effect as soon as the law is enacted.
Key points:
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced June 20, 2025 by Brian Babin · Last progress June 20, 2025